Corcept Therapeutics’ (CORT) CEO Joseph Belanoff on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Joseph Belanoff Thank you Charlie and thank all of you for joining us. Before I discuss our Cushing syndrome franchise oncology research and development of our next generation compounds I’ll describe the … more

View todays social media effects on CORT

View the latest stocks trending across Twitter. Click to view dashboard

See who Corcept is hiring next, click here to view